Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03515200
Title Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia
Recruitment Terminated
Gender
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphoblastic leukemia

Therapies

Cytarabine + Dexamethasone + Methotrexate

Bortezomib + Dasatinib + Dexamethasone + Doxorubicin + Palbociclib

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.